Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

NCT01829958 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

201

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin Lymphoma (NHL)
Diffuse Large B-cell Lymphoma (DLBCL)

Interventions

DRUG: rituximab
DRUG: prednisone
BEHAVIORAL: Geriatric Assessment

Sponsor

Memorial Sloan Kettering Cancer Center